Want to see SBC full AI Analyst Report?
SBC Medical Group Holdings (SBC) Ratios
40 Followers
SBC Medical Group Holdings Ratios
SBC's free cash flow for Q2 2026 was $22.04M. For the 2026 fiscal year, SBC's free cash flow was decreased by $-464.95K and operating cash flow was $22.51M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 3.78 | 3.01 | 1.79 | 1.12 |
| Quick Ratio | 3.74 | 2.99 | 1.76 | 1.10 |
| Cash Ratio | 2.68 | 2.04 | 1.11 | 0.51 |
| Solvency Ratio | 0.46 | 0.71 | 0.45 | 0.10 |
| Operating Cash Flow Ratio | 0.64 | 0.34 | 0.55 | -0.00 |
| Short-Term Operating Cash Flow Coverage | 4.28 | 167.23 | 14.37 | -0.01 |
| Net Current Asset Value | $ 114.08M | $ 113.39M | $ 50.91M | $ -4.68M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.14 | 0.05 | 0.09 | 0.07 |
| Debt-to-Equity Ratio | 0.21 | 0.06 | 0.16 | 0.15 |
| Debt-to-Capital Ratio | 0.17 | 0.06 | 0.14 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.12 | 0.03 | 0.08 | 0.05 |
| Financial Leverage Ratio | 1.53 | 1.36 | 1.82 | 2.14 |
| Debt Service Coverage Ratio | 5.82 | 333.72 | 14.24 | 2.40 |
| Interest Coverage Ratio | 420.26 | 2484.23 | 1560.10 | 639.85 |
| Debt to Market Cap | 0.10 | 0.01 | 0.02 | 0.07 |
| Interest Debt Per Share | 0.50 | 0.13 | 0.24 | 1.07 |
| Net Debt to EBITDA | -1.32 | -1.46 | -0.93 | -1.20 |
| Profitability Margins | ||||
| Gross Profit Margin | 73.32% | 75.97% | 70.94% | 65.94% |
| EBIT Margin | 47.36% | 35.77% | 38.04% | 13.61% |
| EBITDA Margin | 48.91% | 37.62% | 44.37% | 17.02% |
| Operating Profit Margin | 38.87% | 34.23% | 36.51% | 11.55% |
| Pretax Profit Margin | 47.27% | 35.76% | 38.02% | 13.59% |
| Net Profit Margin | 29.37% | 22.69% | 20.34% | 3.63% |
| Continuous Operations Profit Margin | 29.40% | 22.73% | 19.92% | 3.19% |
| Net Income Per EBT | 62.13% | 63.46% | 53.51% | 26.67% |
| EBT Per EBIT | 121.60% | 104.48% | 104.13% | 117.69% |
| Return on Assets (ROA) | 13.40% | 17.52% | 15.21% | 2.80% |
| Return on Equity (ROE) | 20.54% | 23.89% | 27.69% | 6.00% |
| Return on Capital Employed (ROCE) | 21.13% | 34.31% | 42.48% | 16.19% |
| Return on Invested Capital (ROIC) | 12.61% | 21.34% | 21.31% | 3.56% |
| Return on Tangible Assets | 16.07% | 17.94% | 16.72% | 2.95% |
| Earnings Yield | 11.49% | 8.68% | 3.87% | 4.11% |
| Efficiency Ratios | ||||
| Receivables Turnover | 3.27 | 4.26 | 3.64 | 3.99 |
| Payables Turnover | 2.63 | 3.40 | 2.12 | 3.87 |
| Inventory Turnover | 16.59 | 33.02 | 18.19 | 43.94 |
| Fixed Asset Turnover | 10.61 | 14.63 | 9.92 | 8.10 |
| Asset Turnover | 0.46 | 0.77 | 0.75 | 0.77 |
| Working Capital Turnover Ratio | 1.18 | 2.09 | 4.55 | 0.00 |
| Cash Conversion Cycle | -5.35 | -10.78 | -51.94 | 5.52 |
| Days of Sales Outstanding | 111.64 | 85.63 | 100.20 | 91.47 |
| Days of Inventory Outstanding | 22.00 | 11.05 | 20.06 | 8.31 |
| Days of Payables Outstanding | 138.99 | 107.46 | 172.20 | 94.26 |
| Operating Cycle | 133.64 | 96.69 | 120.26 | 99.78 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | 0.38 | 0.21 | 0.54 | -0.00 |
| Free Cash Flow Per Share | 0.35 | 0.18 | 0.42 | -1.66 |
| Dividend Paid and CapEx Coverage Ratio | 16.42 | 6.04 | 4.52 | -0.00 |
| Capital Expenditure Coverage Ratio | 16.42 | 6.04 | 4.52 | -0.00 |
| Operating Cash Flow Coverage Ratio | 0.75 | 1.69 | 2.21 | -0.00 |
| Operating Cash Flow to Sales Ratio | 0.22 | 0.10 | 0.26 | -0.00 |
| Free Cash Flow Yield | 8.23% | 3.20% | 3.88% | -16.26% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | 8.62 | 11.58 | 25.84 | 24.34 |
| Price-to-Sales (P/S) Ratio | 2.56 | 2.61 | 5.26 | 0.88 |
| Price-to-Book (P/B) Ratio | 1.79 | 2.75 | 7.16 | 1.46 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.15 | 31.26 | 25.80 | -6.15 |
| Price-to-Operating Cash Flow Ratio | 11.41 | 26.08 | 20.09 | -3244.36 |
| Price-to-Earnings Growth (PEG) Ratio | 2.07 | 0.81 | 0.02 | 0.00 |
| Enterprise Value Multiple | 3.91 | 5.49 | 10.91 | 3.98 |
| Enterprise Value | 331.78M | 424.05M | 937.12M | 118.07M |
| EV to EBITDA | 3.91 | 5.49 | 10.91 | 3.98 |
| EV to Sales | 1.91 | 2.06 | 4.84 | 0.68 |
| EV to Free Cash Flow | 9.08 | 24.69 | 23.76 | -4.72 |
| EV to Operating Cash Flow | 8.52 | 20.60 | 18.50 | -2492.64 |
| Tangible Book Value Per Share | 1.94 | 1.96 | 1.28 | 6.42 |
| Shareholders’ Equity Per Share | 2.41 | 2.02 | 1.51 | 6.99 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.38 | 0.36 | 0.48 | 0.77 |
| Revenue Per Share | 1.69 | 2.13 | 2.05 | 11.56 |
| Net Income Per Share | 0.50 | 0.48 | 0.42 | 0.42 |
| Tax Burden | 0.62 | 0.63 | 0.54 | 0.27 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.34 | 0.34 | 0.34 | 0.54 |
| Stock-Based Compensation to Revenue | 0.00 | 0.06 | 0.00 | 0.00 |
| Income Quality | 0.76 | 0.44 | 1.29 | -0.01 |
Currency in USD
